{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:02:44Z","timestamp":1766023364355,"version":"3.48.0"},"reference-count":36,"publisher":"e-Century Publishing Corporation","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Exp Immunol"],"DOI":"10.62347\/rsat7482","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T22:30:53Z","timestamp":1741300253000},"page":"23-33","source":"Crossref","is-referenced-by-count":2,"title":["PYGO2 as a novel prognostic biomarker and its correlation with immune infiltrates in liver cancer"],"prefix":"10.62347","volume":"14","author":[{"given":"Jieyu","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J and Finn RS. Hepatocellular carcinoma. Nat Rev Dis Primers 2021; 7: 6.","journal-title":"Nat Rev Dis Primers"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hep.31165","article-title":"Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma","volume":"73","author":"Ahn","year":"2021","unstructured":"Ahn JC, Teng PC, Chen PJ, Posadas E, Tseng HR, Lu SC and Yang JD. Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma. Hepatology 2021; 73: 422-436.","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1158\/1541-7786.MCR-07-0068","article-title":"Oncogenic activation of the human Pygopus2 promoter by E74-like factor-1","volume":"6","author":"Andrews","year":"2008","unstructured":"Andrews PG, Kennedy MW, Popadiuk CM and Kao KR. Oncogenic activation of the human Pygopus2 promoter by E74-like factor-1. Mol Cancer Res 2008; 6: 259-266.","journal-title":"Mol Cancer Res"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Zhu Y, Zhao Y, Wen J, Liu S, Huang T, Hatial I, Peng X, Al Janabi H, Huang G, Mittlesteadt J, Cheng M, Bhardwaj A, Ashfeld BL, Kao KR, Maeda DY, Dai X, Wiest O, Blagg BSJ, Lu X, Cheng L, Wan J and Lu X. Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancer. Sci Immunol 2023; 8: eade4656.","DOI":"10.1126\/sciimmunol.ade4656"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1158\/1078-0432.CCR-05-2433","article-title":"Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer","volume":"12","author":"Popadiuk","year":"2006","unstructured":"Popadiuk CM, Xiong J, Wells MG, Andrews PG, Dankwa K, Hirasawa K, Lake BB and Kao KR. Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer. Clin Cancer Res 2006; 12: 2216-2223.","journal-title":"Clin Cancer Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/01478885.2019.1610214","article-title":"PYGO2 as an independent diagnostic marker expressed in a majority of colorectal cancers","volume":"42","author":"Soleymani","year":"2019","unstructured":"Soleymani S, Khales SA, Jafarian AH, Kalat HR and Forghanifard MM. PYGO2 as an independent diagnostic marker expressed in a majority of colorectal cancers. J Histotechnol 2019; 42: 98-103.","journal-title":"J Histotechnol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1021\/acs.jproteome.3c00389","article-title":"IL18R1-related molecules as biomarkers for asthma severity and prognostic markers for idiopathic pulmonary fibrosis","volume":"22","author":"Lin","year":"2023","unstructured":"Lin K, Wang T, Tang Q, Chen T, Lin M, Jin J, Cao J, Zhang S, Xing Y, Qiao L and Liang Y. IL18R1-related molecules as biomarkers for asthma severity and prognostic markers for idiopathic pulmonary fibrosis. J Proteome Res 2023; 22: 3320-3331.","journal-title":"J Proteome Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.62347\/UGPH7404","article-title":"Exploring the role of NAA40 in immune infiltrates and prognostic prediction in hepatocellular carcinoma","volume":"13","author":"Zhou","year":"2024","unstructured":"Zhou T, Cao J, Tang Q, Jin J, Liang Y and Feng B. Exploring the role of NAA40 in immune infiltrates and prognostic prediction in hepatocellular carcinoma. Am J Clin Exp Immunol 2024; 13: 26-34.","journal-title":"Am J Clin Exp Immunol"},{"key":"ref8","unstructured":"Feng B, Zhou T, Guo Z, Jin J, Zhang S, Qiu J, Cao J, Li J, Peng X, Wang J, Xing Y, Ji R, Qiao L and Liang Y. Comprehensive analysis of immune-related genes for classification and immune microenvironment of asthma. Am J Transl Res 2023; 15: 1052-1062."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y and He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 2012; 16: 284-287.","journal-title":"OMICS"},{"key":"ref10","unstructured":"Zhang S, Lin K, Qiu J, Feng B, Wang J, Li J, Peng X, Ji R, Qiao L and Liang Y. Identification of potential key autophagy-related genes in asthma with bioinformatics approaches. Am J Transl Res 2022; 14: 7350-7361."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H&#xE4","year":"2013","unstructured":"Hänzelmann S, Castelo R and Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 2013; 14: 7.","journal-title":"BMC Bioinformatics"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12672-023-00756-6","article-title":"Identification of hepatocellular carcinoma-related subtypes and development of a prognostic model: a study based on ferritinophagy-related genes","volume":"14","author":"Wang","year":"2023","unstructured":"Wang G, Li J, Zhu L, Zhou Z, Ma Z, Zhang H, Yang Y, Niu Q and Wang X. Identification of hepatocellular carcinoma-related subtypes and development of a prognostic model: a study based on ferritinophagy-related genes. Discov Oncol 2023; 14: 147.","journal-title":"Discov Oncol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","unstructured":"Llovet JM, Montal R, Sia D and Finn RS. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol 2018; 15: 599-616.","journal-title":"Nat Rev Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","article-title":"Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2021","unstructured":"Llovet JM, De Baere T, Kulik L, Haber PK, Greten TF, Meyer T and Lencioni R. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2021; 18: 293-313.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","article-title":"Evolving therapeutic landscape of advanced hepatocellular carcinoma","volume":"20","author":"Yang","year":"2023","unstructured":"Yang C, Zhang H, Zhang L, Zhu AX, Bernards R, Qin W and Wang C. Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2023; 20: 203-222.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jhep.2021.09.007","article-title":"NAFLD-driven HCC: safety and efficacy of current and emerging treatment options","volume":"76","author":"Foerster","year":"2022","unstructured":"Foerster F, Gairing SJ, Müller L and Galle PR. NAFLD-driven HCC: safety and efficacy of current and emerging treatment options. J Hepatol 2022; 76: 446-457.","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0092-8674(02)00679-7","article-title":"Wnt\/wingless signaling requires BCL9\/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex","volume":"109","author":"Kramps","year":"2002","unstructured":"Kramps T, Peter O, Brunner E, Nellen D, Froesch B, Chatterjee S, Murone M, Züllig S and Basler K. Wnt\/wingless signaling requires BCL9\/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell 2002; 109: 47-60.","journal-title":"Cell"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1042\/BJ20121667","article-title":"Evidence of a novel role for Pygopus in rRNA transcription","volume":"453","author":"Andrews","year":"2013","unstructured":"Andrews PG, He Z, Tzenov YR, Popadiuk C and Kao KR. Evidence of a novel role for Pygopus in rRNA transcription. Biochem J 2013; 453: 61-70.","journal-title":"Biochem J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/jclinpath-2017-204718","article-title":"PYGOPUS2 expression in prostatic adenocarcinoma is a potential risk stratification marker for PSA progression following radical prostatectomy","volume":"71","author":"Kao","year":"2018","unstructured":"Kao KR, Popadiuk P, Thoms J, Aoki S, Anwar S, Fitzgerald E, Andrews P, Voisey K, Gai L, Challa S, He Z, Gonzales-Aguirre P, Simmonds A and Popadiuk C. PYGOPUS2 expression in prostatic adenocarcinoma is a potential risk stratification marker for PSA progression following radical prostatectomy. J Clin Pathol 2018; 71: 402-411.","journal-title":"J Clin Pathol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12079-015-0314-6","article-title":"Role of Msi1 and PYGO2 in esophageal squamous cell carcinoma depth of invasion","volume":"10","author":"Moghbeli","year":"2016","unstructured":"Moghbeli M, Sadrizadeh A, Forghanifard MM, Mozaffari HM, Golmakani E and Abbaszadegan MR. Role of Msi1 and PYGO2 in esophageal squamous cell carcinoma depth of invasion. J Cell Commun Signal 2016; 10: 49-53.","journal-title":"J Cell Commun Signal"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12079-018-0476-0","article-title":"Immunohistochemistry analysis of Pygo2 expression in central nervous system tumors","volume":"13","author":"Liang","year":"2019","unstructured":"Liang Y, Wang C, Chen A, Zhu L, Zhang J, Jiang P, Yue Q and De G. Immunohistochemistry analysis of Pygo2 expression in central nervous system tumors. J Cell Commun Signal 2019; 13: 75-84.","journal-title":"J Cell Commun Signal"},{"key":"ref22","unstructured":"Andrews PG, Lake BB, Popadiuk C and Kao KR. Requirement of Pygopus 2 in breast cancer. Int J Oncol 2007; 30: 357-363."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1158\/1541-7786.MCR-12-0510","article-title":"Human papilloma virus (HPV) E7-mediated attenuation of retinoblastoma (Rb) induces hPygopus2 expression via Elf-1 in cervical cancer","volume":"11","author":"Tzenov","year":"2013","unstructured":"Tzenov YR, Andrews PG, Voisey K, Popadiuk P, Xiong J, Popadiuk C and Kao KR. Human papilloma virus (HPV) E7-mediated attenuation of retinoblastoma (Rb) induces hPygopus2 expression via Elf-1 in cervical cancer. Mol Cancer Res 2013; 11: 19-30.","journal-title":"Mol Cancer Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"11074","DOI":"10.18632\/oncotarget.3570","article-title":"Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing E-cadherin expression","volume":"6","author":"Zhang","year":"2015","unstructured":"Zhang S, Li J, Liu P, Xu J, Zhao W, Xie C, Yin Z and Wang X. Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing E-cadherin expression. Oncotarget 2015; 6: 11074-11086.","journal-title":"Oncotarget"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/1471-2407-13-346","article-title":"Abnormal expression of Pygopus 2 correlates with a malignant phenotype in human lung cancer","volume":"13","author":"Liu","year":"2013","unstructured":"Liu Y, Dong QZ, Wang S, Fang CQ, Miao Y, Wang L, Li MZ and Wang EH. Abnormal expression of Pygopus 2 correlates with a malignant phenotype in human lung cancer. BMC Cancer 2013; 13: 346.","journal-title":"BMC Cancer"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"80612","DOI":"10.18632\/oncotarget.13016","article-title":"The role of Pygo2 for Wnt\/ß-catenin signaling activity during intestinal tumor initiation and progression","volume":"7","author":"Talla","year":"2016","unstructured":"Talla SB and Brembeck FH. The role of Pygo2 for Wnt\/ß-catenin signaling activity during intestinal tumor initiation and progression. Oncotarget 2016; 7: 80612-80632.","journal-title":"Oncotarget"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"22066","DOI":"10.1038\/srep22066","article-title":"Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1\/MLL2 complex recruitment","volume":"6","author":"Zhou","year":"2016","unstructured":"Zhou C, Zhang Y, Dai J, Zhou M, Liu M, Wang Y, Chen XZ and Tang J. Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1\/MLL2 complex recruitment. Sci Rep 2016; 6: 22066.","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcancer.2023.03.004","article-title":"Role of E2F transcription factor in oral cancer: recent insight and advancements","volume":"92","author":"Kassab","year":"2023","unstructured":"Kassab A, Gupta I and Moustafa AA. Role of E2F transcription factor in oral cancer: recent insight and advancements. Semin Cancer Biol 2023; 92: 28-41.","journal-title":"Semin Cancer Biol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00432-023-05527-y","article-title":"An update of predictive biomarkers related to WEE1 inhibition in cancer therapy","volume":"150","author":"Wang","year":"2024","unstructured":"Wang Z, Li W, Li F and Xiao R. An update of predictive biomarkers related to WEE1 inhibition in cancer therapy. J Cancer Res Clin Oncol 2024; 150: 13.","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"5509","DOI":"10.2147\/CMAR.S320193","article-title":"An update on the potential roles of E2F family members in colorectal cancer","volume":"13","author":"Xu","year":"2021","unstructured":"Xu Z, Qu H, Ren Y, Gong Z, Ri HJ and Chen X. An update on the potential roles of E2F family members in colorectal cancer. Cancer Manag Res 2021; 13: 5509-5521.","journal-title":"Cancer Manag Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"625257","DOI":"10.3389\/fonc.2021.625257","article-title":"Comprehensive analysis of E2F family members in human gastric cancer","volume":"11","author":"Li","year":"2021","unstructured":"Li S, Yang X, Li W and Chen Z. Comprehensive analysis of E2F family members in human gastric cancer. Front Oncol 2021; 11: 625257.","journal-title":"Front Oncol"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Li F, Yan J, Leng J, Yu T, Zhou H, Liu C, Huang W, Sun Q and Zhao W. Expression patterns of E2Fs identify tumor microenvironment features in human gastric cancer. PeerJ 2024; 12: e16911.","DOI":"10.7717\/peerj.16911"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12964-024-01513-0","article-title":"The dynamic role of nucleoprotein SHCBP1 in the cancer cell cycle and its potential as a synergistic target for DNA-damaging agents in cancer therapy","volume":"22","author":"Zhou","year":"2024","unstructured":"Zhou M, Duan L, Chen J, Li Y, Yin Z, Song S, Cao Y, Luo P, Hu F, Yang G, Xu J, Liao T and Jin Y. The dynamic role of nucleoprotein SHCBP1 in the cancer cell cycle and its potential as a synergistic target for DNA-damaging agents in cancer therapy. Cell Commun Signal 2024; 22: 131.","journal-title":"Cell Commun Signal"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"822","DOI":"10.4314\/ahs.v20i2.36","article-title":"Effect of interleukins (IL-2, IL-15, IL-18) on receptors activation and cytotoxic activity of natural killer cells in breast cancer cell","volume":"20","author":"Widowati","year":"2020","unstructured":"Widowati W, Jasaputra DK, Sumitro SB, Widodo MA, Mozef T, Rizal R, Kusuma HSW, Laksmitawati DR, Murti H, Bachtiar I and Faried A. Effect of interleukins (IL-2, IL-15, IL-18) on receptors activation and cytotoxic activity of natural killer cells in breast cancer cell. Afr Health Sci 2020; 20: 822-832.","journal-title":"Afr Health Sci"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1158\/0008-5472.CAN-14-3590","article-title":"CCL5-mediated Th2 immune polarization promotes metastasis in luminal breast cancer","volume":"75","author":"Zhang","year":"2015","unstructured":"Zhang Q, Qin J, Zhong L, Gong L, Zhang B, Zhang Y and Gao WQ. CCL5-mediated Th2 immune polarization promotes metastasis in luminal breast cancer. Cancer Res 2015; 75: 4312-4321.","journal-title":"Cancer Res"}],"container-title":["American Journal of Clinical and Experimental Immunology"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcei\/14\/1\/ajcei0162632.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:57:49Z","timestamp":1766023069000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcei\/14\/1\/ajcei0162632.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/rsat7482","relation":{},"ISSN":["2164-7712"],"issn-type":[{"type":"electronic","value":"2164-7712"}],"subject":[],"published":{"date-parts":[[2025]]}}}